Machine Learning Improves Risk Stratification in Myelofibrosis

Machine Learning is a subsection in the field of Artificial Intelligence. How can this be used as a tool in hematology-oncology for advanced disease prognostification and beyond? Adrián Mosquera-Orgueira and Juan Carlos Hernández-Boluda, two co-authors of the HemaSphere published article Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis, discuss with host Dr Stephen Hibbs the challenges and outcomes in utilizing a novel myelofibrosis survival model that aids in risk stratification for patients diagnosed with myelofibrosis.
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis, is on our website, all major podcast platforms (Spotify, Apple Podcast, etc), and UA-cam. Listen and enjoy casual, insightful discussions about #hematology research.
You can find the referenced article, in full and open access, here on the HemaSphere website.
journals.lww.c...